Advertisement
"We are excited about exhibiting at the NCVH conference and showcasing ourproducts at the event," states Cathy Bradshaw, President of Wound CareInnovations. "It is an excellent opportunity to be with the industry leadersand promote our advanced wound care product, CellerateRx(R) especially at sucha crucial point of our revenue generation cycle of the product."
Advertisement
The Company also has announced that they have expanded their sales teamthrough the addition of Lisa DiRisio as Senior Account Manager. Lisa, who hassignificant experience in the wound care industry from her time at Smith &Nephew, will also be in attendance at the conference. Cathy Bradshaw furtherstates, "We are very excited to have Lisa join our team and bring a wealth ofvalue to the Company through her background and wound care relationships. Postour announcement of our independent studies of CellerateRX we have hadmultiple revenue leads and believe through the further build out of our teamwith individuals such as Lisa that we will be able to significantly expand ourrevenue generation in the near term."
About Wound Management Technologies, Inc.:
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with itscorporate headquarters in Fort Worth, Texas, markets and distributes woundcare products to the healthcare market under patented technology licensed tothe Company. The Company is positioned and seeks to be a leading provider ofwound care products. For more information on the Company please visit theCompany's Website at http://www.Celleraterx.com .
"Safe Harbor" Statement: Under The Private Securities Litigation ReformAct of 1995: The statements in the press release that relate to the company'sexpectations with regard to the future impact on the company's results fromnew products in development are "forward-looking statements," within themeaning of the Private Securities Litigation Reform Act of 1995. Since thisinformation may contain statements that involve risk and uncertainties and aresubject to change at any time, the company's actual results may differmaterially from expected results. This document may contain forward-lookingstatements concerning the Company's operations, current and future performanceand financial condition. These items involve risks and uncertainties such asproduct demand, market and customer acceptance, the effect of economicconditions, competition, pricing, the ability to consummate and integrateacquisitions, and other risks and uncertainties detailed in the Company's SECfilings. The Company undertakes no obligation to revise any of thesestatements to reflect the future circumstances or the occurrence ofunanticipated events.For Further Information: Product Information Shareholder Relations Cathy Bradshaw Lucy Singleton President Secretary 954-315-9242 817-820-7080
SOURCE Wound Management Technologies, Inc.
